New Venture Capital Funding Opportunities in Cancer Drug Development

Online, October 1, 2013 (Newswire.com) - OmicsX has announced its market research studies outcome on the Oncology Venture Funding. The study covers 321 investment firms, with their venture investments in more than 500 oncology companies and covers more than 3000 financing series investment details in past 10 years.

Cancer is one of the challenging diseases that lack proper treatment and early diagnosis. The recent years seen major upsurge in cancer research funding both from private and government institutions. Oncology Drug Funding 2013 - a funding intelligence report measures the worldwide contribution of 321 active private funding investors including top venture capital firms, private equity firms and major angel investor groups worldwide.

The 570 pages report covers largest set of oncology focused investor firm profiles covering all early, mid to growth fund investors having an active investments in oncology companies, thus shall be very helpful to new and existing entrepreneurs in identifying several new investment firms for funding their innovations in cancer diagnostic, device and drug development.

Thus is a Perfect Guide to provide complete Landscape on Oncology Drug Funding.

How this Report will help :-

CXOs / Directors / VPs

- First innovative report to provide insights on several new strategic/financial investors willing to fund your company's growth.

- Identify key venture partners contribution and strategic positions on Company 's Board.

- Detailed series co-investors details to identify best investors consortium for your needs.

- Access to Numerous deals, structure & size to analyze true value of business model.

Venture Partners

- Identify new emerging players in drug funding, with their core team and funding preferences.

- De-risk the venture by getting real insights through a comprehensive picture.

- Infographics design with focused and interactive content, takes no time in filling knowledge gaps.

- Virtually cover all oncology focused funding deals occurs in past 10 years with their valuation sizes.

Start-ups / Entrepreneurs

- Clearly identify - who will invest in your business and to which extent.

- Quickly navigate the complete profiles of focused Investors and their investment strategies.

- Identify the extent of funding in each round/series to meet your immediate and future needs.

- To design and negotiate on better financial plans to unlock the real value of innovation/assets.

- Directly get in touch with oncology focused Venture Partner through Linkedin & E-mail ID.

Analysts/ Consultants

- Explore Top Investors and eliminate your hours of digital search and data curating.

- Spend quality time in analyzing finer funding details & decisions making.

- Identify paradigm shift in oncology drug funding; with 10 years of funding history covering 500+ companies and 3000+ Deals.

- Closely monitor wining deals and M&A activities by bringing more data under analysis.

For further details visit : http://www.omicsx.com/cancer_drug_funding.html

or contact

Virendra Singhvi

Manager- Business Development

U.S.A/Canada/Singapore +1 646-513-4433

Europe/U.K +44 203-608-3536

Asia/India/China +91 562-228-1122
Contact
OmicsX
Virendra Singhvi